Dechra Pharmaceuticals PLC (GB:DPH)

Dechra Pharmaceuticals (DPH) Share Price & Analysis


DPH Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range2,446.04p - 4,000.00p
Previous Close3,340p
Average Volume (3M)1.18M
Market Cap
Enterprise Value426.58B
Total Cash (Recent Filing)£87.90M
Total Debt (Recent Filing)£511.20M
Price to Earnings (P/E)92.4
Sep 04, 2023
EPS EstimateN/A
0.45 (0.01%)
Share Statistics
EPS (TTM)0.36
Shares Outstanding113,824,190
10 Day Avg. Volume360,330
30 Day Avg. Volume1,182,970
Standard Deviation0.08
Financial Highlights & Ratios
Price to Book (P/B)-1415.73
Price to Sales (P/S)1096.02
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside15.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5

Dechra Pharmaceuticals News




What was Dechra Pharmaceuticals PLC’s price range in the past 12 months?
Dechra Pharmaceuticals PLC lowest share price was 2446.04p and its highest was 4000.00p in the past 12 months.
    What is Dechra Pharmaceuticals PLC’s market cap?
    Currently, no data Available
    When is Dechra Pharmaceuticals PLC’s upcoming earnings report date?
    Dechra Pharmaceuticals PLC’s upcoming earnings report date is Sep 04, 2023 which is in 94 days.
      How were Dechra Pharmaceuticals PLC’s earnings last quarter?
      Dechra Pharmaceuticals PLC released its earnings results on Feb 27, 2023. The company reported 0.554p earnings per share for the quarter, beating the consensus estimate of N/A by 0.554p.
        Is Dechra Pharmaceuticals PLC overvalued?
        According to Wall Street analysts Dechra Pharmaceuticals PLC’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Dechra Pharmaceuticals PLC pay dividends?
          Dechra Pharmaceuticals PLC pays a Annually dividend of 12.5p which represents an annual dividend yield of 1.35%. See more information on Dechra Pharmaceuticals PLC dividends here
            What is Dechra Pharmaceuticals PLC’s EPS estimate?
            Dechra Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Dechra Pharmaceuticals PLC have?
            Dechra Pharmaceuticals PLC has 113,884,140 shares outstanding.
              What happened to Dechra Pharmaceuticals PLC’s price movement after its last earnings report?
              Dechra Pharmaceuticals PLC reported an EPS of 0.554p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.214%.
                Which hedge fund is a major shareholder of Dechra Pharmaceuticals PLC?
                Currently, no hedge funds are holding shares in GB:DPH


                Dechra Pharmaceuticals Stock Smart Score

                The Dechra Pharmaceuticals Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Dechra Pharmaceuticals PLC

                Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.


                Top 5 ETFs holding DPH

                Market Value
                Smart Score
                dbxt FTSE ALL-S Shs -1D- Distribution
                Franklin FTSE United Kingdom ETF
                SPDR FTSE UK All Share UCITS ETF
                SPDR UK All Sh Accum.Shs GBP
                Lyxor Core UK Equity All Cap (DR) UCITS ETF
                Up to five ETFs with an Outperform Smart Score that hold DPH. The ETFs are listed according to market value of DPH within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Avacta Group plc
                Advanced Oncotherapy
                C4X Discovery Holdings
                EKF Diagnostics Holdings

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis